Scynexis to Recall Antifungal on Cross Contamination Risk Scynexis to Recall Antifungal on Cross Contamination Risk

Scynexis said on Monday it would voluntarily recall its antifungal pill, which it has licensed to GSK, due to risk of cross-contamination with a potential allergy-inducing compound.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news